Effectivenessof L-Arginine supplementation for treatment of patients with pulmonary tuberculosis

Not Applicable

• Conditions: Tuberculosis.; Tuberculosis of lung, confirmed by sputum microscopy with or without culture

• Registration Number: IRCT201211179855N2
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

adults over 15 years ;New cases of positive sputum smear
Exclusion criteria: pregnant women ; aged under 15 years, ;patients who During the past month received L-arginine ; Sensitivity to L - arginine

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improved paraclinical tests. Timepoint: days of 14 , 28 , 42 , 56. Method of measurement: check of CRP.;Improved paraclinical tests. Timepoint: days of 14 , 28 , 42 , 56. Method of measurement: check of ESR.;Improved paraclinical tests. Timepoint: days of 14 , 28 , 42 , 56. Method of measurement: check of CBC.

Secondary Outcome Measures

Name	Time	Method
Improve of life quality. Timepoint: 0 and 56. Method of measurement: standard questionairof GHQ-28.;Accelerating weight gain. Timepoint: 0 AND56. Method of measurement: Weight measurement.